Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% versus 3% versus 6% nebulised saline. Dwyer TJ, Elkins MR, Dentice R, Forbes S, et al. Eur Respir J 2023;62:2100960.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dwyer TJ, Elkins MR, Dentice R, Forbes S, et al. Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% versus 3% versus 6% nebulised saline. Eur Respir J 2023;62:2100960.
PMID: 37343977